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Abstract
Background: Intraorbital metastases of breast cancer is rare with only 3-10% of all ocular metastases. We report a
case of orbital metastases as first sign of systemic metastatic spread in a female patient with breast cancer.
Methods: The patient had been diagnosed with breast cancer 3 years before. Her present complain was local pain,
diplopia and periorbital swelling. A CT scan revealed extensive bony destruction of the orbital roof/anterior skull
base. Bone scintigraphy demonstrated additional uptake at the level of the skull base, cervical spine, ilium and ribs
suggesting metastatic spread to the skeleton. A navigation-assisted intraorbital biopsy from the orbital roof
revealed a metastasis of breast cancer. With the confirmed diagnosis of metastatic breast cancer the patient was
refered to the oncologist for further tumor staging. As further treatment she received systemic palliative
chemotherapy in addition to intravenous treatment with bisphosphonates.
Conclusion: In patients with a previous history of breast cancer who complain even of mild ophthalmologic
symptoms such as local pain, periorbital edema, it is important to consider ocular or orbital metastatic disease.
Adequate 3D-Imaging followed by a biopsy will usually confirm the diagnosis.
Keywords: Orbital metastasis, breast cancer, navigation-assisted surgery
Introduction
Orbital metastases occur in 2% to 3% of patients with can-
cer. Metastases of breast cancer account for the majority
of ocular and orbital metastases [1]. Clinical signs and
symptoms may include proptosis, diplopia, pain, exopthal-
mus, blurred vision and a visible or palpable tumor mass
in the orbital or periorbital region. The overall prognosis
of patients with orbital metastasis is generally poor. In
12-31% of the affected patients [2-4] eye metastases are
the first sign of malignant disease or metastatic spread.
Once the diagnosis has been established treatment is
mainly with palliative intention and focuses on symptom
relief and improvement of orbital function as long as
possible.
We report a case in which orbital metastasis of breast
cancer was diagnosed with a navigation-assisted surgical
biopsy. Further clinical staging revealed previously
unknown multifocal skeletal metastasis.
In addition diagnosis and treatment concepts of orbi-
tal metastases will be reported.
Case report
A 73-year old woman presented with a 3-week history of
left orbital pain with slight exophthalmus. Three years
before the patient had been diagnosed with breast carci-
noma cT4 cN1. The tumor was ER/PR positive and
HER2-neu negative. The initial treatment consisted of
neoadjuvant chemotherapy with epirubicin/cyclophospha-
mide (EC-protocol) followed by surgical tumor ablation
and dissection of the left axilla. Postoperative external
beam radiation of the thoracic wall was performed. After
completion of the initial treatment with complete remis-
sion the patients further clinical course was uneventful.
Due to the positive receptor status antihormonal therapy
with anastrozole was initiated.
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swelling and exophthalmus. (Figure 1 and 2). The
patient complained of left orbital pain and diplopia.
There were no clinical signs of neuromuscular dysfunc-
tion of the eye or any other neurological disorder. CT
imaging studies were suspicious for left orbital metasta-
sis with a suprabulbar tumor mass, sized 3 × 4 cm, with
osseous infiltration of the orbital roof and lateral orbital
wall, frontal skull base and sphenoid wing (Figure 3 and
4). General restaging, which was then performed,
showed multifocal osseous metastases of the skull base,
cervical spine, right femur, left ilium and ribs (Figure 5).
For diagnostic confirmation a biopsy taken from the left
orbital roof was planned. As a first step for technical
and surgical planning DICOM data of the patient were
imported into the planning application iPlan3.0 (Brain-
Lab
®). (Figure 6). An MRI dataset was used to deter-
mine the position and shape of the tumor structure,
while a CT dataset was used to determine the patients
anatomical structure and to plan reference points for
the surgery. The tumor shape itself is outlined manually
by several tools for brushing. If its shape has been fina-
lized, target points for taking a biopsy could be planned
as well (Figure 7). Using an upper eyelid crease incision
the tumor area was approached by blunt dissection.
Intraoperative using pointer-assisted navigation the
tumor region was approached and a representative snap
biopsy was taken. The pathology report confirmed the
diagnosis of a metastatic poorly differentiated invasive
ductal carcinoma of the breast; further immunohisto-
chemical staining demonstrated ER/PR positivity, posi-
tive staining for HER-2/neu and Ki67 Index of 40%. The
postoperative course was completely uneventful with no
ocular morbidity. The patient was discharged on the 3
rd
postoperative day. She was referred to the oncologist for
further systemic chemotherapy and bisphosphonate
treatment. Currently she receives hormonal therapy with
daily tamoxifen 20 mg; in addition bisphosphonate treat-
ment with 4 mg zolendronate/monthly was initiated.
Local radiotherapy of the left orbit and skull base will
be reserved in case of progression of ocular symptoms.
Discussion
Typical manifestations of orbital metastases include a
palpable mass causing displacement or proptosis of the
globe, pain, inflammation, bone involvement, chemosis,
and eyelid swelling [5].
Metastases to the eye and orbit have been described for
a variety of solid tumors, but breast carcinoma accounts
for the majority of ocular and orbital metastases [6-9]. In
breast cancer - the most frequent cause of cancer-related
death in women [10] - orbital metastases have been
Figure 1 73-year old patient with left orbital swelling and
slight ptosis and proptosis. Clinically an firm mass was palpable
that persisted for about 3 weeks causing pain and diplopia.
Figure 2 Axial view shows left orbital swelling with ptosis and
proptosis.
Figure 3 The axial CT scan shows an infiltrating tumor mass
with bony destruction of lateral orbital wall and skullbase.
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[1,11,12]. Orbital metastases from breast cancer tend to
infiltrate the extraocular muscle and surrounding orbital
fat, causing motility deficits. The histology features of
adenocarcinoma of the breast vary, and the histologic
features of orbital metastases may differ from the primary
tumor.
Patients who have been diagnosed with orbital metas-
tases usually carry a poor prognosis: the mean survival
after diagnosis of such metastases is 31 months (range,
1-116 months) [13]. Even if the orbit is the only clinical
suspected site of metastatic involvement, the likelihood
of further distant metastases in other organs is high as
was shown in our patient following further staging
procedures.
Treatment of orbital metastases aims at improving
patient’s quality of life and restore or preserve visual
function. Usually treatment of orbital and ocular metas-
tases is palliative and may include radiotherapy, systemic
chemotherapy, hormonal therapy, or surgery in selected
patients.
Radiotherapy is the mainstay for orbital and ocular
metastases and appears to be safe and effective with
objective response rates up to 79% [14]. Radiotherapy
improves symptoms in 80% of cases and restores vision
in some cases [15]. However, cataract formation and
radiation retinopathy are potential side effects of exter-
nal beam radiotherapy; these potential sequelae must be
balanced against the overall prognosis and survival of
the individual patient [12,16]. Systemic chemotherapy is
another mainstay in the palliative setting of orbital
metastases; in addition the initiation of bisphosphonate
Figure 5 Technetium-Bone scintigraphy reveals multiple
osseous lesions in the skeleton suspicious for metastases of
the breast cancer.
Figure 7 The current position of the pointer tip is visualized
by a green line in all reconstruction views in real-time. The
actual landmark or biopsy position is marked by a red cross. These
positions are saved and could be transferred to planning data post-
operatively.
Figure 4 The coronal CT scan reveals large tumor mass of the
left orbit with bony destruction of orbital roof and lateral
orbital wall as well as skullbase infiltration.
Figure 6 Preoperative multiplanar imaging using the iPlan3.0
software (Brainlab
®) allows for segmentation of the tumor
area and virtual planning of the biopsy.
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diagnosed. Novel targeted systemic treatments are
increasingly used in addition to cytostatic chemotherapy.
Recently, one case of dramatic local response of a uni-
lateral choroidal metastasis in Her2/neu-positive breast
cancer to systemic therapy with trastuzumab and vinor-
elbine was reported [17].
In general, extensive orbital surgery to remove the
metastasis is not recommended as this is not curative
and may be associated with significant ocular morbidity
[15]. Enucleation or rather radical measures offer no
advantages in terms of progression or survival and should
only be used in cases of intractable ocular pain or unma-
nageable local hygiene due to rapid tumor growth [5].
The only appropriate surgical intervention for breast car-
cinoma metastatic to the orbit is a biopsy to establish the
diagnosis [5].
In summary, although rare, breast cancer patients can
develop metastases to the orbital and ocular region.
Patients with a history of breast cancer presenting with
ocular symptoms such as ptosis, proptosis, diplopia, pain,
exophthalmus should be evaluated for orbital metastases.
Once diagnosis is confirmed treatment for patients with
orbital metastases is multidisciplinary.
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